Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 14.31
-4.54 %
$ 4.05 B
Market Cap
57.24
P/E
CASH FLOW STATEMENT
-148 M
OPERATING CASH FLOW
-215 M
INVESTING CASH FLOW
266 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Sotera Health Company
| Net Income | 51.4 M |
| Depreciation & Amortization | 160 M |
| Capital Expenditures | -215 M |
| Stock-Based Compensation | 32.2 M |
| Change in Working Capital | -403 M |
| Others | -358 M |
| Free Cash Flow | -363 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | 51.4 | (233.6) | 117.1 | (37.5) | (20.4) | (5.9) |
| Depreciation & Amortization | 160.3 | 145.6 | 150.9 | 143.6 | 146.7 | 146.8 |
| Deferred Income Tax | 3.4 | (74.0) | (3.7) | (23.4) | (19.0) | (45.3) |
| Stock Based Compensation | 32.2 | 21.2 | 13.9 | 11.0 | 6.9 | 6.9 |
| Other Operating Activities | 8.2 | 9.5 | 16.0 | 38.7 | 43.2 | 13.0 |
| Change in Working Capital | (403.3) | 409.2 | (12.6) | (11.8) | (8.4) | 4.0 |
| Cash From Operations | (147.7) | 278.0 | 281.5 | 120.6 | 149.0 | 119.6 |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (215.0) | (182.4) | (102.2) | (53.5) | (57.3) | (72.6) |
| Other Items | 69 K | 0.5 | (57.7) | (105.2) | 0 | 169.3 |
| Cash From Investing Activities | (214.9) | (181.9) | (159.8) | (158.7) | (57.3) | 96.6 |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | (4.1) | (0.4) | (1.4) | (34.0) | 0 | 0 |
| Total Debt Repaid | 297.5 | 200.0 | (100.0) | (1 027.3) | 583.5 | (14.6) |
| Dividends Paid | 0 | 0 | 0 | 0 | (691.2) | (175.8) |
| Other Financing Activities | (27.5) | (1.8) | (15.9) | (21.2) | (18.4) | (1.4) |
| Cash From Financing Activities | 266.0 | 197.8 | (117.3) | 73.4 | (126.0) | (191.9) |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (94.6) | 289.4 | 4.5 | 39.4 | (33.8) | 20.7 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (362.7) | 95.6 | 179.4 | 67.1 | 91.8 | 47.0 |